AMED icon

Amedisys

91.91 USD
-0.07
0.08%
At close Jan 17, 4:00 PM EST
After hours
91.91
+0.00
0.00%
1 day
-0.08%
5 days
0.25%
1 month
7.66%
3 months
-4.99%
6 months
-5.97%
Year to date
1.11%
1 year
-2.94%
5 years
-49.03%
10 years
226.62%
 

About: Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Employees: 19,000

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% less capital invested

Capital invested by funds: $2.74B [Q2] → $2.73B (-$7.28M) [Q3]

3% less funds holding

Funds holding: 280 [Q2] → 272 (-8) [Q3]

4.78% less ownership

Funds ownership: 91.16% [Q2] → 86.37% (-4.78%) [Q3]

8% less funds holding in top 10

Funds holding in top 10: 12 [Q2] → 11 (-1) [Q3]

11% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 47

25% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 99

84% less call options, than puts

Call options by funds: $15.6M | Put options by funds: $97.6M

Research analyst outlook

We haven’t received any recent analyst ratings for AMED.

Financial journalist opinion

Based on 6 articles about AMED published over the past 30 days

Negative
Zacks Investment Research
1 week ago
UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through
UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.
UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through
Negative
Zacks Investment Research
3 weeks ago
Reasons to Retain AMED Stock in Your Portfolio Now
Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Reasons to Retain AMED Stock in Your Portfolio Now
Neutral
Proactive Investors
3 weeks ago
UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) and Amedisys (NASDAQ:AMED) have agreed to extend the deadline for their $3.3 billion merger, facing ongoing scrutiny from the US Department of Justice (DOJ). The companies announced in a regulatory filing that the merger deadline will now be extended to 10 days after a final court decision is issued or December 31, 2025, whichever comes first.
UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny
Neutral
Investopedia
3 weeks ago
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
Positive
Benzinga
3 weeks ago
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Neutral
Reuters
3 weeks ago
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal
UnitedHealth and Amedisys have agreed to extend the deadline to close their $3.3 billion merger agreement to next year, a filing showed on Friday, as the deal faces close scrutiny from the U.S. Department of Justice.
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal
Negative
Zacks Investment Research
2 months ago
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
Negative
Reuters
2 months ago
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market for home health services, the department said.
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
Negative
Reuters
2 months ago
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports
The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloomberg News reported on Tuesday, citing people familiar with the matter.
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports
Negative
Zacks Investment Research
2 months ago
AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls
Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls
Charts implemented using Lightweight Charts™